Cited by 938Cytokine Signaling Pathways and InteractionsInflammasome and immune disordersT-cell and B-cell Immunology

Interleukin-18 and IL-18 Binding Protein

Open access
Dinarello, Charles A., Novick, Daniela, Kim, Soohyun, Kaplanski, Gilles·2013·Frontiers in Immunology

Abstract

Interleukin-18 (IL-18) is a member of the IL-1 family of cytokines. Similar to IL-1β, IL-18 is synthesized as an inactive precursor requiring processing by caspase-1 into an active cytokine but unlike IL-1β, the IL-18 precursor is constitutively present in nearly all cells in healthy humans and animals. The activity of IL-18 is balanced by the presence of a high affinity, naturally occurring IL-18 binding protein (IL-18BP). In humans, increased disease severity can be associated with an imbalance of IL-18 to IL-18BP such that the levels of free IL-18 are elevated in the circulation. Increasing number of studies have expanded the role of IL-18 in mediating inflammation in animal models of disease using the IL-18BP, IL-18-deficient mice, neutralization of IL-18, or deficiency in the IL-18 receptor alpha chain. A role for IL-18 has been implicated in several autoimmune diseases, myocardial function, emphysema, metabolic syndromes, psoriasis, inflammatory bowel disease, hemophagocytic syndromes, macrophage activation syndrome, sepsis, and acute kidney injury, although in some models of disease, IL-18 is protective. IL-18 plays a major role in the production of interferon-γ from T-cells and natural killer cells. The IL-18BP has been used safely in humans and clinical trials of IL-18BP as well as neutralizing anti-IL-18 antibodies are in clinical trials. This review updates the biology of IL-18 as well as its role in human disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2013.00289

Cites

126 of 126 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • IL18BP normally prevents interleukin-18 from binding to its receptor, keeping the proinflammatory effects of interleukin-18 in check.

    “The proinflammatory effects of interleukin-18 are normally kept in check by the interleukin-18–binding protein (IL18BP), which prevents the binding of interleukin-18 to its receptor.46”

    From Cytokine storm (2020) · cites this paper as [46]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Dinarello, C. A., Novick, D., Kim, S., & Kaplanski, G.
Affiliations
  • University of Colorado Denver (US)
  • Weizmann Institute of Science (IL)
  • Konkuk University (KR)
  • Aix-Marseille Université (FR)
Corresponding author
Dinarello, Charles A.
Venue
Frontiers in Immunology
Published
2013
Volume
4
Pages
289-289
ISSN
1664-3224 (ISSN-L)
OpenAlex
W2064856766
Cited by
938
References
126
Citations by year
2026: 50 · 2025: 46 · 2024: 84 · 2023: 107 · 2022: 112 · 2021: 109 · 2020: 80 · 2019: 75 · 2018: 66 · 2017: 66 · 2016: 56 · 2015: 49 · 2014: 35 · 2013: 2
FWCI
5.00
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Frontiers in Immunology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Radboud Repository (Radboud University) (submittedVersion)
  • Radboud Repository (Radboud University) (submittedVersion, other-oa)
Funders
  • Agence Nationale de la Recherche
  • National Institutes of Health (CA-04-6934, 15614, AI‐15614)
  • National Institute of Allergy and Infectious Diseases (R56AI015614, R01AI015614)
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR045584)
Topics
  • Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords
IL-18, IL-18 binding protein, IL-1 family cytokines, inflammation, autoimmune disease, interferon-gamma, natural killer cells, sepsis, acute kidney injury, macrophage activation syndrome, hemophagocytic lymphohistiocytosis, inflammatory bowel disease, psoriasis, emphysema, metabolic syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review